SYNERGY MEDICAL TECHNOLOGIES LTD

Company Registration Number:
08542746 (England and Wales)

Unaudited statutory accounts for the year ended 31 May 2024

Period of accounts

Start date: 01 June 2023

End date: 31 May 2024

SYNERGY MEDICAL TECHNOLOGIES LTD

Contents of the Financial Statements

for the Period Ended 31 May 2024

Company Information - 3
Balance sheet - 4
Additional notes - 6
Balance sheet notes - 10

SYNERGY MEDICAL TECHNOLOGIES LTD

Company Information

for the Period Ended 31 May 2024




Director: Carl Judd Crawshaw Brammah
Karen Elaine Collingwood
Registered office: 4
East Lockside
Brighton Marina Village
Brighton
East Sussex
England
BN2 5HA
Company Registration Number: 08542746 (England and Wales)

SYNERGY MEDICAL TECHNOLOGIES LTD

Balance sheet

As at 31 May 2024


Notes

2024
£

2023
£
Fixed assets
Tangible assets: 5 1,697 2,245
Total fixed assets: 1,697 2,245
Current assets
Stocks: 15,021 27,660
Debtors: 6 151,938 156,336
Cash at bank and in hand: 183 1,347
Total current assets: 167,142 185,343
Creditors: amounts falling due within one year: 7 ( 24,747 ) ( 42,042 )
Net current assets (liabilities): 142,395 143,301
Total assets less current liabilities: 144,092 145,546
Creditors: amounts falling due after more than one year: 8 ( 118,323 ) ( 97,542 )
Provision for liabilities: ( 561 )
Total net assets (liabilities): 25,769 47,443

The notes form part of these financial statements

SYNERGY MEDICAL TECHNOLOGIES LTD

Balance sheet continued

As at 31 May 2024


Notes

2024
£

2023
£
Capital and reserves
Called up share capital: 20,000 20,000
Profit and loss account: 5,769 27,443
Shareholders funds: 25,769 47,443

For the year ending 31 May 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 11 February 2025
And Signed On Behalf Of The Board By:

Name: Carl Judd Crawshaw Brammah
Status: Director

Name: Karen Elaine Collingwood
Status: Director

The notes form part of these financial statements

SYNERGY MEDICAL TECHNOLOGIES LTD

Notes to the Financial Statements

for the Period Ended 31 May 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

SYNERGY MEDICAL TECHNOLOGIES LTD

Notes to the Financial Statements

for the Period Ended 31 May 2024

  • 2. Employees


    2024

    2023
    Average number of employees during the period 3 5

SYNERGY MEDICAL TECHNOLOGIES LTD

Notes to the Financial Statements

for the Period Ended 31 May 2024

  • 3. Off balance sheet disclosure

    No

SYNERGY MEDICAL TECHNOLOGIES LTD

Notes to the Financial Statements

for the Period Ended 31 May 2024

4. Dividends


2024
£

2023
£
Dividends paid 40,000 42,120

SYNERGY MEDICAL TECHNOLOGIES LTD

Notes to the Financial Statements

for the Period Ended 31 May 2024

5. Tangible assets

Fixtures & fittings Office equipment Total
Cost £ £ £
At 01 June 2023 1,697 548 2,245
Additions - - -
Disposals - - -
Revaluations - - -
Transfers - - -
At 31 May 2024 1,697 548 2,245
Depreciation
At 01 June 2023 - - -
Charge for year - 548 548
On disposals - - -
Other adjustments - - -
At 31 May 2024 - 548 548
Net book value
At 31 May 2024 1,697 0 1,697
At 31 May 2023 1,697 548 2,245

SYNERGY MEDICAL TECHNOLOGIES LTD

Notes to the Financial Statements

for the Period Ended 31 May 2024

6. Debtors


2024
£

2023
£
Trade debtors 15,255 33,182
Other debtors 136,683 123,154
Total 151,938 156,336

SYNERGY MEDICAL TECHNOLOGIES LTD

Notes to the Financial Statements

for the Period Ended 31 May 2024

7.Creditors: amounts falling due within one year note


2024
£

2023
£
Bank loans and overdrafts 4,929 25,153
Trade creditors 13,864 9,566
Taxation and social security 0 1,169
Other creditors 5,954 6,154
Total 24,747 42,042

SYNERGY MEDICAL TECHNOLOGIES LTD

Notes to the Financial Statements

for the Period Ended 31 May 2024

8.Creditors: amounts falling due after more than one year


2024
£

2023
£
Bank loans and overdrafts 118,323 97,542
Total 118,323 97,542